T. Rowe Price Capital Appreciation Premium Income ETF (TCAL)
| Assets | $86.25M |
| Expense Ratio | 0.34% |
| PE Ratio | 25.57 |
| Shares Out | 3.40M |
| Dividend (ttm) | $0.83 |
| Dividend Yield | 3.40% |
| Ex-Dividend Date | Jul 28, 2025 |
| Payout Frequency | Monthly |
| Payout Ratio | 87.30% |
| Volume | 401,442 |
| Open | 24.29 |
| Previous Close | 24.53 |
| Day's Range | 24.29 - 24.55 |
| 52-Week Low | 23.24 |
| 52-Week High | 29.81 |
| Beta | n/a |
| Holdings | 188 |
| Inception Date | Mar 26, 2025 |
About TCAL
Fund Home PageThe T. Rowe Price Capital Appreciation Premium Income ETF (TCAL) is an exchange-traded fund. The ETF currently has 83.95m in AUM and 78 holdings. TCAL is actively managed, utilizing a covered call options strategy with US stocks TCAL was launched on Mar 26, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
21.01% of assets| Name | Symbol | Weight |
|---|---|---|
| Yum! Brands, Inc. | YUM | 2.18% |
| Stryker Corporation | SYK | 2.18% |
| American Electric Power Company, Inc. | AEP | 2.14% |
| The Coca-Cola Company | KO | 2.13% |
| Keurig Dr Pepper Inc. | KDP | 2.10% |
| Gilead Sciences, Inc. | GILD | 2.10% |
| L3Harris Technologies, Inc. | LHX | 2.07% |
| Thermo Fisher Scientific Inc. | TMO | 2.06% |
| Cardinal Health, Inc. | CAH | 2.05% |
| Abbott Laboratories | ABT | 2.00% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jul 28, 2025 | $0.2046 | Jul 30, 2025 |
| Jun 25, 2025 | $0.2176 | Jun 27, 2025 |
| May 27, 2025 | $0.2371 | May 29, 2025 |
| Apr 25, 2025 | $0.1749 | Apr 29, 2025 |
Performance
News
Diversify Your Income Portfolio With These 2 Equity ETFs
U.S. equity markets hit fresh highs on Monday on earnings optimism while Treasury yields fell. Despite new gains, potential trouble continues to brew in the background, particularly for bonds.
T. Rowe's Tim Gilligan Digs Into TCAL
As investors become more educated and more comfortable with options strategies, understanding the nuances of individual strategies within the category may help advisors select the best fund for their ...
T. Rowe ETFs: Active Benefits at Competitive Prices
This year's market environment remains a favorable one for active ETFs, with approximately 40% of flows funneling into the strategies year-to-date. As investors increasingly look beyond benchmark cons...